Quest diagnostics launches covid-19 rapid antigen test with observed collection for consumers through questdirect™

Secaucus, n.j. and miami, jan. 26, 2022 /prnewswire/ -- quest diagnostics (nyse: dgx), the world's leading provider of diagnostic information services, today announced the availability of an at-home covid-19 rapid antigen test service for consumer purchase, available through questdirect™, the company's consumer-initiated testing platform.
DGX Ratings Summary
DGX Quant Ranking